micronavigation ELN path item Treat. Research path item Quality of Life and Late Effects  · 

Quality of Life and Late Effects

Created by: Ihrig , generated 2010/02/25 , last changed: 2010/03/02

Due to increasing cure rates quality of life and late effects are becoming more and more research objectives of the scientific community - furthermore quality of life and late effects are potential new endpoints for clinical trials. Research in this field helps to optimise trial design and aftercare of the patients.


Table of Content:

 

Print this Document   Sitemap   Contact  
EUTOS
EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe More ...
ESF
The ELN is funded through a Research Networking Programme (RNP), initiated by the European Science Foundation More ...
ELN Foundation
The ELN Foundation is a non-profit charitable organisation, which supports the goals of the European LeukemiaNet More ...


 
top